Key result
The pathophysiology of pulmonary hypertension in heart failure with preserved ejection fraction remains uncertain, with implications for diagnosis and management.
Why the study?
Knowledge regarding the pathophysiology of pulmonary hypertension in HFpEF remains uncertain, carrying practical implications for diagnosis and treatment.
This review discusses the pathophysiological bases of pulmonary hypertension in heart failure with preserved ejection fraction and its implications for management.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Freitas et al. (2022) conducted a review in Pulmonary hypertension in heart failure with preserved ejection fraction. The pathophysiology of pulmonary hypertension in heart failure with preserved ejection fraction remains uncertain, with implications for diagnosis and management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: